Surmodics

SRDX

$39.40arrow_drop_up0.25%$0.10

SRDX

$39.40

arrow_drop_up0.25%$0.10

Performance History

There's no data available for key stats

There's no data available for ratios/profitability stats

Score Breakdown

There's no data available for score breakdown

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Surmodics (SRDX)

Surmodics Inc (SRDX) is a leading provider of medical device and diagnostic products that improve patient outcomes and enhance the delivery of healthcare. With a focus on developing innovative solutions, Surmodics has built a strong reputation for quality and reliability in the industry. The company's commitment to continuous improvement and customer satisfaction has helped it maintain a loyal customer base and drive long-term growth. Surmodics' product portfolio includes a wide range of technologies and services, such as drug delivery systems, surface modification technologies, and in vitro diagnostic test kits.

Surmodics Inc's stock price history reflects the company's success and growth. Over the years, the stock has shown steady appreciation, with occasional fluctuations due to market conditions. Investors who have held onto Surmodics stock have been rewarded with solid returns. The company's consistent financial performance and strong market position have contributed to its overall value and market capitalization. As of [date], Surmodics Inc has a market capitalization of [market cap].

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Gary R. Maharaj
Headquarters: Eden Prairie
Employees: 447
Exchange: NASDAQ

Keep an eye on Surmodics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Surmodics 's (SRDX) price per share?

The current price per share for Surmodics (SRDX) is $39.4. The stock has seen a price change of $0.1 recently, indicating a 0.25% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Surmodics (SRDX)?

For Surmodics (SRDX), the 52-week high is $42.44, which is 7.72% from the current price. The 52-week low is $25.17, the current price is 56.54% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Surmodics (SRDX) a growth stock?

Surmodics (SRDX) has shown an average price growth of 0.41% over the past three years. It has received a score of 26 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Surmodics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Surmodics (SRDX) stock price performance year to date (YTD)?

As of the latest data, Surmodics (SRDX) has a year-to-date price change of 10.8%. Over the past month, the stock has experienced a price change of -1.79%. Over the last three months, the change has been -6.08%. Over the past six months, the figure is 41.78%. Looking at a longer horizon, the five-year price change stands at -14.33%.

help

Is Surmodics (SRDX) a profitable company?

Surmodics (SRDX) has a net income of -$1.54M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 46.03% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -17.7% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $132.58M, with a revenue growth rate of 32.65%, providing insight into the company's sales performance and growth. The gross profit is $61.02M. Operating income is noted at $5.15M. Furthermore, the EBITDA is $14.95M.

help

What is the market capitalization of Surmodics (SRDX)?

Surmodics (SRDX) has a market capitalization of $560.69M. The average daily trading volume is 308.66K, indicating the stock's liquidity and investor engagement.